CARDIOLIPIN IGG ANTIBODY^

The Cardiolipin IgG Antibody test measures immunoglobulin G antibodies directed against cardiolipin, a phospholipid component of cell membranes. Detection of anti‑cardiolipin IgG is used to assess antiphospholipid antibody presence and helps evaluate risk for thrombosis, pregnancy loss, and other complications associated with antiphospholipid syndrome (APS); testing is performed by sensitive immunoassay methods on a venous blood sample collected at home by a trained phlebotomist and processed in accredited UAE laboratories.

This test is recommended for individuals with unexplained arterial or venous clots, recurrent miscarriages, early stroke, or in patients with autoimmune conditions such as systemic lupus erythematosus who require antiphospholipid screening. Home collection across Dubai and the UAE offers convenience, timely sample transport to certified labs, and secure electronic reporting so clinicians can rapidly use results to guide anticoagulation, pregnancy planning, or further rheumatology/hematology evaluation.

• Cardiolipin IgG Antibody
• Antibody Titre (GPL units)
• Result Interpretation (Negative / Low‑Positive / High‑Positive)

• After an unexplained venous or arterial thrombotic event
• Following recurrent pregnancy loss or unexplained infertility
• Young stroke or transient ischemic attack without clear cause
• When systemic lupus erythematosus or other autoimmune disease is suspected
• Preconception screening or high‑risk obstetric assessment

• Convenient at‑home blood collection by trained phlebotomists in Dubai and UAE
• Testing in accredited laboratories using validated immunoassays
• Fast turnaround and secure electronic reporting for clinicians and patients
• Supports clinical decisions on anticoagulation, pregnancy management, and specialist referral
• Confidential handling and UAE‑compliant health records and reporting

• At‑home venous blood sample collection by a certified phlebotomist
• No special fasting required unless otherwise instructed by clinician
• Inform the collector about current anticoagulant, immunosuppressive, or intravenous immunoglobulin therapies
• Provide clinical history of thrombotic events or pregnancy complications when booking